Advanced Functional Materials · 2014 · 15 citations · 0 references
PharmacyBiophysicsChemistryDrug DeliveryMolecular ImagingTheranosticsContrast AgentsMultimodal ImagingNanomedicinePhotodynamic TherapyPhotothermal TherapyTheranostic NanoparticlesCancer Photodynamic TherapyMultifunctional NanoplatformsNanoparticle Imaging AgentsNanoparticle-based Contrast AgentsPhotosensitizersPhotothermal EffectsPorphyrin ComplexesT1-weighted Imaging
Adv. Funct. Mater, 2014, 24, 6492–6502 In the above article, two references were excluded in the originally published version. The inclusion requires the following modifications to the text. The following sentence, which appears on page 2: “Although it is well know that porphyrin and its derivatives can serve as chelating molecules to capture metal ions,[36, 37] the use of metalloporphyrin as MR contrast agents has not yet been reported to our best knowledge.” should read: “It is well know that porphyrin and its derivatives can serve as chelating molecules to capture metal ions.[36, 37, 60, 61]” And the following sentence, which appears in the Conclusion on page 9: “In this system, we for the first time uncover that Ce6, a porphin-based photosensitizer, could form a chelate with Gd3+ to allow T1-weighted MR imaging.” should read: “In this system, we uncover that Ce6, a porphin-based photosensitizer, could form a chelate with Gd3+ to allow T1-weighted MR imaging.” The additional references are: [60] X.-a. Zhang, K. S. Lovejoy, A. Jasanoff, S. J. Lippard, Proc. Natl. Acad. Sci. USA 2007, 104, 10780. [61] T. D. MacDonald, T. W. Liu, G. Zheng, Angew. Chem. Int. Ed. 2014, DOI: 10.1002/ange.201400133. The authors apologize for this omission and for any confusion that may have been caused as a result.